KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD

Sandra J. Taler, Rajiv Agarwal, George L. Bakris, Joseph T. Flynn, Peter M. Nilsson, Mahboob Rahman, Paul W. Sanders, Stephen C. Textor, Matthew R. Weir, Raymond R. Townsend

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

In response to the 2012 KDIGO (Kidney Disease: Improving Global Outcomes) guideline for blood pressure management in patients with chronic kidney disease not on dialysis, the National Kidney Foundation organized a group of US experts in hypertension and transplant nephrology to review the recommendations and comment on their relevancy in the context of current US clinical practice and concerns. The overriding message was the dearth of clinical trial evidence to provide strong evidence-based recommendations. For patients with CKD with normal to mildly increased albuminuria, goal blood pressure has been relaxed to ≤140/90 mm Hg for both diabetic and nondiabetic patients. In contrast, KDIGO continues to recommend goal blood pressure ≤130/80 mm Hg for patients with chronic kidney disease with moderately or severely increased albuminuria and for all renal transplant recipients regardless of the presence of proteinuria, without supporting data. The expert panel thought the KDIGO recommendations were generally reasonable but lacking in sufficient evidence support and that additional studies are greatly needed.

Original languageEnglish
Pages (from-to)201-213
Number of pages13
JournalAmerican Journal of Kidney Diseases
Volume62
Issue number2
DOIs
StatePublished - Aug 2013

Fingerprint

Practice Management
Kidney Diseases
Practice Guidelines
Blood Pressure
Albuminuria
Chronic Renal Insufficiency
Kidney
Nephrology
Proteinuria
Dialysis
Clinical Trials
Guidelines
Hypertension
Transplants

Keywords

  • blood pressure
  • guideline
  • Kidney Disease: Improving Global Outcomes (KDIGO)

ASJC Scopus subject areas

  • Nephrology

Cite this

KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. / Taler, Sandra J.; Agarwal, Rajiv; Bakris, George L.; Flynn, Joseph T.; Nilsson, Peter M.; Rahman, Mahboob; Sanders, Paul W.; Textor, Stephen C.; Weir, Matthew R.; Townsend, Raymond R.

In: American Journal of Kidney Diseases, Vol. 62, No. 2, 08.2013, p. 201-213.

Research output: Contribution to journalArticle

Taler, SJ, Agarwal, R, Bakris, GL, Flynn, JT, Nilsson, PM, Rahman, M, Sanders, PW, Textor, SC, Weir, MR & Townsend, RR 2013, 'KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD', American Journal of Kidney Diseases, vol. 62, no. 2, pp. 201-213. https://doi.org/10.1053/j.ajkd.2013.03.018
Taler, Sandra J. ; Agarwal, Rajiv ; Bakris, George L. ; Flynn, Joseph T. ; Nilsson, Peter M. ; Rahman, Mahboob ; Sanders, Paul W. ; Textor, Stephen C. ; Weir, Matthew R. ; Townsend, Raymond R. / KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. In: American Journal of Kidney Diseases. 2013 ; Vol. 62, No. 2. pp. 201-213.
@article{e8cd2c39bf844e9aa7cd0ece296c808d,
title = "KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD",
abstract = "In response to the 2012 KDIGO (Kidney Disease: Improving Global Outcomes) guideline for blood pressure management in patients with chronic kidney disease not on dialysis, the National Kidney Foundation organized a group of US experts in hypertension and transplant nephrology to review the recommendations and comment on their relevancy in the context of current US clinical practice and concerns. The overriding message was the dearth of clinical trial evidence to provide strong evidence-based recommendations. For patients with CKD with normal to mildly increased albuminuria, goal blood pressure has been relaxed to ≤140/90 mm Hg for both diabetic and nondiabetic patients. In contrast, KDIGO continues to recommend goal blood pressure ≤130/80 mm Hg for patients with chronic kidney disease with moderately or severely increased albuminuria and for all renal transplant recipients regardless of the presence of proteinuria, without supporting data. The expert panel thought the KDIGO recommendations were generally reasonable but lacking in sufficient evidence support and that additional studies are greatly needed.",
keywords = "blood pressure, guideline, Kidney Disease: Improving Global Outcomes (KDIGO)",
author = "Taler, {Sandra J.} and Rajiv Agarwal and Bakris, {George L.} and Flynn, {Joseph T.} and Nilsson, {Peter M.} and Mahboob Rahman and Sanders, {Paul W.} and Textor, {Stephen C.} and Weir, {Matthew R.} and Townsend, {Raymond R.}",
year = "2013",
month = "8",
doi = "10.1053/j.ajkd.2013.03.018",
language = "English",
volume = "62",
pages = "201--213",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD

AU - Taler, Sandra J.

AU - Agarwal, Rajiv

AU - Bakris, George L.

AU - Flynn, Joseph T.

AU - Nilsson, Peter M.

AU - Rahman, Mahboob

AU - Sanders, Paul W.

AU - Textor, Stephen C.

AU - Weir, Matthew R.

AU - Townsend, Raymond R.

PY - 2013/8

Y1 - 2013/8

N2 - In response to the 2012 KDIGO (Kidney Disease: Improving Global Outcomes) guideline for blood pressure management in patients with chronic kidney disease not on dialysis, the National Kidney Foundation organized a group of US experts in hypertension and transplant nephrology to review the recommendations and comment on their relevancy in the context of current US clinical practice and concerns. The overriding message was the dearth of clinical trial evidence to provide strong evidence-based recommendations. For patients with CKD with normal to mildly increased albuminuria, goal blood pressure has been relaxed to ≤140/90 mm Hg for both diabetic and nondiabetic patients. In contrast, KDIGO continues to recommend goal blood pressure ≤130/80 mm Hg for patients with chronic kidney disease with moderately or severely increased albuminuria and for all renal transplant recipients regardless of the presence of proteinuria, without supporting data. The expert panel thought the KDIGO recommendations were generally reasonable but lacking in sufficient evidence support and that additional studies are greatly needed.

AB - In response to the 2012 KDIGO (Kidney Disease: Improving Global Outcomes) guideline for blood pressure management in patients with chronic kidney disease not on dialysis, the National Kidney Foundation organized a group of US experts in hypertension and transplant nephrology to review the recommendations and comment on their relevancy in the context of current US clinical practice and concerns. The overriding message was the dearth of clinical trial evidence to provide strong evidence-based recommendations. For patients with CKD with normal to mildly increased albuminuria, goal blood pressure has been relaxed to ≤140/90 mm Hg for both diabetic and nondiabetic patients. In contrast, KDIGO continues to recommend goal blood pressure ≤130/80 mm Hg for patients with chronic kidney disease with moderately or severely increased albuminuria and for all renal transplant recipients regardless of the presence of proteinuria, without supporting data. The expert panel thought the KDIGO recommendations were generally reasonable but lacking in sufficient evidence support and that additional studies are greatly needed.

KW - blood pressure

KW - guideline

KW - Kidney Disease: Improving Global Outcomes (KDIGO)

UR - http://www.scopus.com/inward/record.url?scp=84880644910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880644910&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2013.03.018

DO - 10.1053/j.ajkd.2013.03.018

M3 - Article

C2 - 23684145

AN - SCOPUS:84880644910

VL - 62

SP - 201

EP - 213

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 2

ER -